Literature DB >> 20971512

A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers.

Bob Oranje1, Malene Wienberg, Birte Y Glenthoj.   

Abstract

Early mechanisms to limit the input of sensory information to higher brain areas are important for a healthy individual. In previous studies, we found that a low dose of 10mg escitalopram (SSRI) disrupts habituation, without affecting sensory and sensorimotor gating in healthy volunteers. In the current study a higher dose of 15 mg was used. The hypothesis was that this higher dose of escitalopram would not only disrupt habituation, but also sensory and sensorimotor gating. Twenty healthy male volunteers received either placebo or 15 mg escitalopram, after which they were tested in a P50 suppression, and a habituation and prepulse inhibition (PPI) of the startle reflex paradigm. Escitalopram significantly decreased P50 suppression and habituation, but had no effect on PPI. The results indicate that habituation and sensory gating are disrupted by increased serotonergic activity, while sensorimotor gating seems relatively insensitive to such a rise. Since the patients who are frequently treated with SSRIs (patients with schizophrenia and affective disorders) might already suffer from disrupted sensory gating and habituation, the current results call for caution in the determination of a proper dose.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971512     DOI: 10.1016/j.psychres.2010.09.019

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Authors:  Boris B Quednow; Michael Kometer; Mark A Geyer; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

2.  Auditory sensory gating in young adolescents with early-onset psychosis: a comparison with attention deficit/hyperactivity disorder.

Authors:  Cecilie Koldbæk Lemvigh; Jens Richardt Møllegaard Jepsen; Birgitte Fagerlund; Anne Katrine Pagsberg; Birte Yding Glenthøj; Jacob Rydkjær; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2019-10-24       Impact factor: 7.853

3.  P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment.

Authors:  Bob Oranje; Bodil Aggernaes; Hans Rasmussen; Bjorn H Ebdrup; Birte Y Glenthøj
Journal:  Schizophr Bull       Date:  2012-01-12       Impact factor: 9.306

4.  Spatio-temporal dynamics of adaptation in the human visual system: a high-density electrical mapping study.

Authors:  Gizely N Andrade; John S Butler; Manuel R Mercier; Sophie Molholm; John J Foxe
Journal:  Eur J Neurosci       Date:  2015-02-16       Impact factor: 3.386

5.  The separate and combined effects of monoamine oxidase inhibition and nicotine on P50 sensory gating.

Authors:  Dylan M Smith; Derek Fisher; Pierre Blier; Vadim Illivitsky; Verner Knott
Journal:  Psychopharmacology (Berl)       Date:  2014-12-04       Impact factor: 4.530

6.  Prepulse Inhibition and P50 Suppression in Relation to Creativity and Attention: Dispersed Attention Beneficial to Quantitative but Not Qualitative Measures of Divergent Thinking.

Authors:  Marije Stolte; Bob Oranje; Johannes E H Van Luit; Evelyn H Kroesbergen
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.